PBAX Annual EBITDA
-$2.91 M
0.00%
31 December 2022
Summary:
As of February 5, 2025, PBAX annual earnings before interest, taxes, depreciation & amortization is -$2.91 millionPBAX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PBAX Quarterly EBITDA
-$429.80 K
+$1.11 M+72.16%
30 September 2023
Summary:
As of February 5, 2025, PBAX quarterly earnings before interest, taxes, depreciation & amortization is -$429.80 thousand, with the most recent change of +$1.11 million (+72.16%) on September 30, 2023. Over the past year, it has increased by +$406.90 thousand (+48.63%).PBAX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PBAX TTM EBITDA
-$3.85 M
+$406.90 K+9.56%
30 September 2023
Summary:
As of February 5, 2025, PBAX TTM earnings before interest, taxes, depreciation & amortization is -$3.85 million, with the most recent change of +$406.90 thousand (+9.56%) on September 30, 2023. Over the past year, it has dropped by -$1.90 million (-97.48%).PBAX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PBAX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +48.6% | -97.5% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
PBAX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | <-9999.0% | <-9999.0% |
Phoenix Biotech Acquisition EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$429.80 K(-72.2%) | -$3.85 M(-9.6%) |
| June 2023 | - | -$1.54 M(+161.5%) | -$4.26 M(+37.8%) |
| Mar 2023 | - | -$590.30 K(-54.1%) | -$3.09 M(+6.4%) |
| Dec 2022 | -$2.91 M | -$1.29 M(+53.9%) | -$2.91 M(+49.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$836.70 K(+122.2%) | -$1.95 M(+75.1%) |
| June 2022 | - | -$376.60 K(-7.0%) | -$1.11 M(+51.1%) |
| Mar 2022 | - | -$404.80 K(+21.9%) | -$736.80 K(+121.9%) |
| Dec 2021 | - | -$332.00 K(<-9900.0%) | -$332.00 K(<-9900.0%) |
| Sept 2021 | - | $0.00 | $0.00 |
FAQ
- What is Phoenix Biotech Acquisition annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Phoenix Biotech Acquisition?
- What is Phoenix Biotech Acquisition quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Phoenix Biotech Acquisition?
- What is Phoenix Biotech Acquisition quarterly EBITDA year-on-year change?
- What is Phoenix Biotech Acquisition TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Phoenix Biotech Acquisition?
- What is Phoenix Biotech Acquisition TTM EBITDA year-on-year change?
What is Phoenix Biotech Acquisition annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of PBAX is -$2.91 M
What is the all time high annual EBITDA for Phoenix Biotech Acquisition?
Phoenix Biotech Acquisition all-time high annual earnings before interest, taxes, depreciation & amortization is -$2.91 M
What is Phoenix Biotech Acquisition quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of PBAX is -$429.80 K
What is the all time high quarterly EBITDA for Phoenix Biotech Acquisition?
Phoenix Biotech Acquisition all-time high quarterly earnings before interest, taxes, depreciation & amortization is $0.00
What is Phoenix Biotech Acquisition quarterly EBITDA year-on-year change?
Over the past year, PBAX quarterly earnings before interest, taxes, depreciation & amortization has changed by +$406.90 K (+48.63%)
What is Phoenix Biotech Acquisition TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of PBAX is -$3.85 M
What is the all time high TTM EBITDA for Phoenix Biotech Acquisition?
Phoenix Biotech Acquisition all-time high TTM earnings before interest, taxes, depreciation & amortization is $0.00
What is Phoenix Biotech Acquisition TTM EBITDA year-on-year change?
Over the past year, PBAX TTM earnings before interest, taxes, depreciation & amortization has changed by -$1.90 M (-97.48%)